Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

M. Bolla, Dionisio González, Padraig Warde et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text

Medicine, Oncology, Urology +15

The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

Sara M. Freeman, Camille N. Abboud, Katharine A. Whartenby et al. · PubMed · 1993 · 1.1K citations

Medicine, Cancer Biology, Oncology +10

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

Miljenko V. Pilepich, Richard Caplan, Roger W. Byhardt et al. · Journal of Clinical Oncology · 1997 · 609 citations

Medicine, Oncology, Urology +17

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

Miljenko V. Pilepich, William T. Sause, William U. Shipley et al. · Urology · 1995 · 489 citations

Medicine, Oncology, Radiation Oncology +17

Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

William U. Shipley, Lynn Verhey, John E. Munzenrider et al. · International Journal of Radiation Oncology*Biology*Physics · 1995 · 410 citations

Medicine, Oncology, Radiation Oncology +15